At the beginning of the pandemic in 2020, Eli Lilly, a pharmaceutical company, joined forces with Junish...
Pharmaceuticals
Advances in Treating Ovarian Cancer
Ovarian cancer is one of the most common forms of cancer affecting female-born patients. About 21,000 people...
EMMA International Named to the 2021 Inc. 5000 List
EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting. We focus on quality, regulatory, and compliance services…
Trends In 2020 FDA Pharma Warning Letters
The recent trend of U.S. Food and Drug Association citations issued to those operating in the pharmaceutical...
Essential Drug Shortages and the FDA
Patients who rely on a consistent supply of needed medication to sustain a normal life, such as insulin or heparin are...
Blood Test Supports Cancer Screening Use
A study published in Annals of Oncology reported that a blood test can successfully detect more than 50 types of...
Stability Testing of Pharmaceuticals and Supplements
Whether you are working on a prescription drug, over-the-counter (OTC) drug, or even a dietary supplement, stability...
Investigating Ketamine for Parkinson’s Disease
In May 2021, the FDA approved an Investigational New Drug (IND) application from PharmaTher Holdings Ltd., to proceed...
Aduhelm, an Accelerated Approval for Alzheimer’s
Alzheimer’s disease is the most common cause of dementia, especially in patients aged 65 and older1. Alzheimer’s...
New COVID-19 Vaccine
Starting in Summer 2021, a new type of COVID vaccine could be available. Known as a protein subunit vaccine, this...
Celebrating Pride Month at EMMA International
June 1 started the celebration of Pride Month, which commemorates Lesbian, Gay, Bisexual, and Transgender members....
Considerations for Biocompatibility Evaluation
Biocompatibility is one of the most critical performance studies that manufacturers need to perform as part of their...
Ready to learn more about working with us?
